Daratumumab,Pomalidomide,Dexamethasone,Bortezomib,Ixazomib,Lenalidomide,Carfilzomib,Elotuzumab,idecabtagene vicleucel
Bms,Janssen,takeda,AbbVie,2Seventy Bio
['ide-cel', 'karmma-3', 'karmma', 'mmsm']
8032 delforge: pros in karmma-3 rct (ide-cel vs soc). improved (and clinically-significant!) global qol &amp; phys/cog fxn, and less fatigue, pain, and less tx side effects in ide-cel arm. glad to see robust pros in #mmsm rcts. #asco23 #celltherapy 
Lymphoma doc & patient-reported outcomes researcher in #lymsm and #mmsm @CUHematology. Founder of https://t.co/kN6qeGFEox, @inTrainingDoc & @inHouseMag. 🏳️‍🌈